What Is Chlorfenapyr and Why Is It Showing Up in Your Vape Cart

If you bought a cannabis vape cartridge in Maine, Colorado, or several other regulated markets in the past year, there is a non-trivial chance that the product was later recalled for containing chlorfenapyr. The regulators who pulled the products said the same thing in each notice: chlorfenapyr is not approved for use on cannabis, inhaling it can cause serious health effects, and consumers should dispose of any affected product.

Most consumers reading those notices have no idea what chlorfenapyr is, why it ended up in cannabis, or what it actually does to a body. The recall language is technical and hedged. The trade press coverage focuses on the brand and recall logistics. The actual science of what's at stake is largely missing from the consumer-facing discussion.

Here is what chlorfenapyr is, why it keeps showing up in legal cannabis, and what you need to know if you've used a product that contained it.

What Chlorfenapyr Actually Is

Chlorfenapyr is a synthetic insecticide and miticide in the pyrazole class of chemicals. It was developed by American Cyanamid Company (later acquired by BASF) and registered with the U.S. Environmental Protection Agency in 2001 for use on certain food crops and ornamental plants.

The chemical works by disrupting the energy production of insects at the cellular level. Specifically, it interferes with mitochondrial function — the process by which cells produce ATP, the energy molecule that powers basic biological processes. When insects ingest or contact chlorfenapyr, their cells lose the ability to produce energy efficiently, which leads to paralysis and death.

The same mechanism that makes chlorfenapyr effective against insects makes it potentially dangerous to mammals, including humans. Mitochondrial function is conserved across species. Substances that disrupt insect mitochondria can disrupt human mitochondria too, particularly at high enough doses or through routes of exposure that bypass normal protective mechanisms.

The EPA approved chlorfenapyr for specific agricultural uses with established residue tolerances and application restrictions. It is approved for use on certain food crops including cotton, soybeans, and some vegetables. It is not approved for use on cannabis. It is not approved for inhalation in any context. The EPA's tolerance standards for chlorfenapyr were developed for dietary exposure — eating residues on food crops — not for inhalation exposure.

Why It's Showing Up in Cannabis

Chlorfenapyr's appearance in cannabis is not a mystery. It happens because the chemical works.

Cannabis cultivators face significant pest pressure, particularly from spider mites, thrips, and various other arthropods that can decimate cannabis crops. The standard pesticides approved for use on cannabis in most states are limited and generally less effective than non-approved alternatives. A cultivator facing a serious pest infestation has a strong economic incentive to reach for whatever works, even if it isn't permitted.

Chlorfenapyr works exceptionally well against the pests that affect cannabis. It is also relatively inexpensive, widely available through agricultural supply channels, and difficult to detect in routine cannabis testing if labs aren't specifically looking for it.

Some cultivators apply chlorfenapyr knowingly, accepting the regulatory risk in exchange for crop protection. Some apply it unknowingly because they purchased nutrients or pesticides that had been adulterated with chlorfenapyr by the manufacturer or by intermediate handlers. Some apply it because their pest control consultants recommended it without disclosing what was actually in the formulation. The supply chain for chemicals used in cannabis cultivation is, in many states, lightly regulated. Adulterated products are common.

Once chlorfenapyr is on the cannabis plant, it persists. The chemical is reasonably stable and does not degrade quickly under normal storage conditions. When the cannabis is processed into concentrates for vape cartridges, the chlorfenapyr concentrates along with the cannabinoids. A vape cartridge made from contaminated flower can contain chlorfenapyr at higher concentrations than the original flower, because the extraction process concentrates everything in the source material.

What It Does When You Inhale It

The toxicology of inhaled chlorfenapyr in humans is not well-studied because the chemical was never approved for human exposure through inhalation. What we know is drawn from animal studies, from a small number of human poisoning cases (typically involving accidental or intentional ingestion in agricultural contexts), and from the documented mechanism of action.

The Maine Office of Cannabis Policy, in its November 2025 vape cartridge recall notice, identified the symptoms associated with inhaling cannabis containing unsafe levels of chlorfenapyr: high fever, sweating, nausea, vomiting, and altered mental status. These symptoms reflect the chemical's mitochondrial mechanism — when energy production is disrupted at scale, the body responds with hyperthermia, gastrointestinal symptoms, and neurological effects.

Severe chlorfenapyr exposure cases documented in the medical literature have involved dramatic clinical presentations including persistent high fever, profuse sweating, muscle weakness, altered consciousness, and in some cases progression to multi-organ dysfunction. The medical literature on chlorfenapyr poisoning notes that severe cases can be difficult to treat because the underlying mitochondrial damage is not directly reversible.

The cases documented in the medical literature have generally involved larger acute exposures than would be expected from a single vape session. The implications of chronic, lower-dose inhalation exposure — the pattern that would result from regular use of contaminated vape cartridges — are less well understood. The honest scientific position is that we don't know exactly what chronic low-dose inhalation chlorfenapyr exposure does to humans, because the studies haven't been done. Animal studies and known mechanism of action suggest that chronic exposure could produce cumulative damage, particularly to tissues with high energy demands such as cardiac muscle, brain, and kidney.

How Much Has Been Pulled From Shelves

The chlorfenapyr-related recalls in legal cannabis have grown progressively over the past year.

Maine. The state's Office of Cannabis Policy issued recall notices on multiple Yani-branded vape cartridge strains and on additional products produced by NorCO Outdoor Cannabis. The recalls covered products sold across Maine adult-use cannabis stores from spring through fall 2025.

Colorado. The Marijuana Enforcement Division has issued multiple chlorfenapyr-related recalls. A January 2026 recall covering Rotation Farms / Rotation LLC products affected nineteen dispensaries. The December 31, 2025 recall on Stash House CO products from CC Brands hit 295 stores across the state — including approximately 75 in Denver, 55 in Colorado Springs, and locations in Aurora, Fort Collins, Boulder, and across the state at chains including Native Roots, The Green Solution, Star Buds, Green Dragon, and Igadi.

Other states. Chlorfenapyr-related recalls have been issued in additional states with regulated cannabis markets, though the scale and frequency vary based on testing requirements and regulatory enforcement capacity.

The pattern across these recalls is consistent. Products that initially passed required testing turn out, on additional testing, to contain chlorfenapyr levels exceeding regulatory tolerances. The contamination has typically been traced to either the cultivation operation directly or to upstream supply chains for nutrients and pest control products.

Why Testing Doesn't Always Catch It

The fact that chlorfenapyr-contaminated products initially pass testing reveals important things about the cannabis testing system.

State testing requirements specify panels of substances that labs must test for. The panels include some pesticides — typically the most commonly used or most concerning — but not all pesticides. Chlorfenapyr is on some state testing panels but not others. In states where it isn't on the required panel, contaminated products can pass testing because the test was never run.

Even in states where chlorfenapyr is on the required panel, detection limits may not be set low enough to catch contamination at concentrations that pose health risks. Testing methodology, sample preparation, and analytical sensitivity all affect whether a contaminated product is identified or not.

Lab fraud, documented in multiple states, can produce false negatives even when proper testing would have caught contamination. A lab that suppresses unfavorable results or fails to run tests can certify products as compliant that are not.

The combined effect is that "passed testing" on a cannabis product is not a guarantee of pesticide-free. It is a statement that the product passed the specific tests that were run, at the specific lab that ran them, on the specific sample provided. The actual contamination status of the bulk product can be different.

What to Do If You've Used Affected Products

If you purchased one of the recalled vape cartridges or other affected products, several considerations.

Check the recall notices. State regulator websites publish recall notices with specific batch numbers, brand names, and dates of sale. Compare your products to the notices. If your product matches, dispose of any remaining product and return packaging to the retailer where possible.

Document any health symptoms. If you have experienced symptoms consistent with chlorfenapyr exposure — persistent fever, unusual sweating, gastrointestinal symptoms, neurological symptoms — document the symptoms with dates and details. Seek medical attention if symptoms are severe.

Report symptoms to regulators. State cannabis regulators often have consumer reporting mechanisms. Reporting symptoms helps regulators document the consumer harm caused by contaminated products and can support enforcement actions. State poison control hotlines can also accept reports.

Consider legal recourse. Class action lawsuits have been filed in multiple states against cannabis brands whose products tested positive for unauthorized pesticides. If you have suffered measurable harm from a recalled product, consult an attorney.

Be skeptical of brand reassurances. Brands whose products have been recalled often issue statements minimizing health concerns. The statements may not reflect the actual evidence about the substance involved. The Maine OCP's specific symptom warnings about chlorfenapyr — high fever, altered mental status — are the regulator's view of the actual risks, not the brand's marketing language.

How to Reduce Your Exposure Going Forward

Eliminating chlorfenapyr exposure from cannabis use is, at this stage of the industry, not fully achievable. Reducing it is.

Avoid mass-market vape cartridges. The bulk of chlorfenapyr-related recalls have involved vape products. Concentrate-based products are particularly vulnerable to pesticide concentration during processing. Combustible flower is not safe by default but typically presents lower exposure profiles than concentrates.

Choose brands with extensive third-party testing. Some brands voluntarily test against pesticide panels broader than what state law requires and publish full results. The premium price reflects the actual cost of clean cultivation. The premium is buying you data.

Look for organic and Clean Green certifications. These certifications require pesticide-free cultivation and are audited annually. The certifications are not federal standards but represent voluntary commitments to clean cultivation.

Be skeptical of low prices on premium-presented products. A vape cartridge selling at premium price points but produced at scale may be using cultivation practices that compromise on cleanliness. The economics of clean cultivation are difficult to reconcile with mass-market pricing.

Subscribe to state regulator recall notifications. Most state cannabis regulators offer email subscriptions for recall notices. Direct notification ensures you find out about recalls quickly enough to dispose of affected products.

Track the chlorfenapyr-specific brand history. Some brands have appeared in multiple recall notices over time. Brands with recurring contamination problems should be deprioritized in your purchasing decisions.

What Has to Change

The chlorfenapyr problem is symptomatic of larger problems in cannabis cultivation and testing that will not be solved by individual consumer behavior alone.

State regulators need to expand mandatory testing panels to include chlorfenapyr and other unauthorized pesticides at detection limits low enough to catch real contamination. Some states have moved in this direction. Many have not.

Cultivation supply chain regulation needs to address the upstream sources of contamination. Adulterated nutrients and pest control products that contain undisclosed chlorfenapyr need to be identified and removed from cannabis supply chains.

Lab integrity measures — random reference samples, blind testing, regulatory audits — need to be sustained at scale to detect and deter the lab fraud that allows contaminated products to pass testing.

Federal cannabis recognition would unlock EPA development of inhalation-specific tolerance standards and would bring the broader infrastructure of pesticide regulation into cannabis cultivation. The current state-by-state patchwork produces inconsistent protection.

Until those changes happen, consumers will continue to bear the cost of an industry that allows chlorfenapyr to reach store shelves. The cost is paid in lung tissue. That deserves to be a story.

---

Internal links:

• Pesticide-Laced Weed: The Recalls, The Brands, The Risk to Your Lungs →
• Fake Lab Results: How Cannabis Testing Labs Are Lying to Consumers →
• Every Cannabis Recall in 2025–2026: A Running List →